Where Tech Meets Bio
Latest News
XtalPi has signed a letter of intent with DoveTree LLC, a company founded by Harvard University professor Gregory Verdine, to develop small molecule and antibody …
Read More
Arc Institute Releases its First Virtual Cell Model
Arc Institute has launched its first virtual cell model, State, designed to predict gene expression changes in response to chemical, genetic, or cytokine perturbations across diverse …
Read More
NVIDIA Releases Agentic AI Blueprint for Literature Review and Target Discovery
NVIDIA has released a new AI-driven workflow, the Biomedical AI-Q Research Agent Developer Blueprint, designed to accelerate the early phases of drug discovery by automating …
Read More
Latest News
Nabla Raises $70M Series C to Expand Agentic AI Platform for Clinical Workflows
Axiom Bio Releases Human Liver Toxicity Dataset with 130,000 Compounds to Advance AI-based Toxicity Prediction
Xaira Publishes Largest Public Perturb-seq Atlas to Advance Virtual Cell Modeling
Agenus and Noetik Partner to Develop AI-Based Biomarkers Using Virtual Cell Models
Isomorphic Labs Appoints Ben Wolf as Chief Medical Officer, Expands to U.S. Hub in Cambridge
Ryght AI Raises $3M to Automate Clinical Trial Site Activation with Agentic AI
Latest Insights
by Dominik Tomicevic
How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment
An estimated 6.9 million Americans aged 65 and older are living with Alzheimer’s. Without major medical breakthroughs, that number is projected to rise to 13.8 …
Read More
by Megan Deegan
What CROs Cite as Their Top Clinical Trial Challenges and How They Plan to Overcome Them in 2025
In a rapidly evolving clinical research landscape, there is a greater need now more than ever for pharma and biotech companies to outsource trial management …
Read More
AI-Based Next-Generation-Phenotyping for Rare Disease Diagnosis
by Adele Ruder, Alexander Hustinx, Louise von Stechow
How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment
by Dominik Tomicevic
Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific
by BiopharmaTrend
Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research
by BiopharmaTrend
AI in Drug Safety: From Concept to Reality, The Industry's Path Forward
by Dr. Karthik Muthusamy
Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development
by Bea Mann, PhD
Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?
by Andreas Dreps, Bea Mann, PhD
The Future of Advanced Therapeutics: Opportunities and Challenges
by Sai Bhamidipati
From Our Partners
Sponsored by
RECEPTOR.AI
This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery
Sponsored by
Trialize
Unlocking Interoperability with AI: How This Company is Building a New Framework for Clinical Trials
Sponsored by
MEDSIR
Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology
Sponsored by
Lantern Pharma
How AI Empowers Biomarker-Driven Clinical Trials
Partner Events

The 12th Aging Research & Drug Discovery Meeting
Event Date: Aug. 25, 2025 - Aug. 29, 2025
Location: Denmark (Ceremonial Hall, University of Copenhagen)
Website: Link

RNA Leaders USA Congress
Event Date: Sept. 10, 2025 - Sept. 11, 2025
Location: United States of America (Boston Exhibition & Convention Center)
Website: Link
Promo Code: MMBioPharmaTrend15
Read more ›››

Interactive Response Technologies 2025
Event Date: Oct. 14, 2025 - Oct. 15, 2025
Location: United States of America (The Westin Copley Place, Boston, MA)
Website: Link
Promo Code: IRT25BPT
Read more ›››
Case Studies
Sponsored by
Roivant Sciences
QUAISAR Computational Platform for Designing Targeted Protein Degraders
Sponsored by
Lantern Pharma
Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®
Sponsored by
Arctoris
Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery
Sponsored by
RECEPTOR.AI
Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy
Sponsored by
Biocompare
Biocompare: Offline Order Attribution Analysis Helps Demonstrate Marketing Effectiveness
Sponsored by
Kymera Therapeutics
Identifying High Impact Tissue Sparing E3 Ligases and Their Binders
Sponsored by
Celeris Therapeutics
Application of AI-driven Xanthos Platform for Designing Protein Degraders
Sponsored by
RECEPTOR.AI
AI Becomes a Drop-in Replacement for Docking
Interviews
Merging AI and Quantum Computing To Boost Drug Discovery
Turbocharging Phenotypic Screening with AI to Target mRNA Biology
Navigating the Crossroads of AI and Oncology: A Deep Dive with Lantern Pharma's CEO, Panna Sharma
Navigating Next Wave of Protein Design with Elise de Reus from Cradle
Most Read
The Growing Impact of AI in Healthcare
Insilico Medicine’s Generative AI Patent Provides Advantage in AI Drug Discovery Race
Cortical Labs Launches $35K Biological Computer Built on Human Brain Cells
The Increasing Role of CROs in the Pharmaceutical Industry